None listed
Conditions
Interventions
IN STAGE 1, TWO FOCUS GROUPS WILL BE CONDUCTED IN EACH OF TWO LOCATIONS: UNIVERSITY OF CALIFORNIA, SAN DIEGO (UCSD) AND YRG CENTER OF AIDS RESEARCH & EDUCATION (YRG CARE), CHENNAI, INDIA. IN EACH LOCA
Sponsors
El Instituto Nacional de Alergia y Enfermedades Infecciosas (NIAID) de los Estados Unidos,
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: STAGE 1 4.1.1 INCLUSION CRITERIA FOR HIV-1 INFECTED INDIVIDUALS ON HAART 1. HIV-1 INFECTION, AS DOCUMENTED BY ANY LICENSED ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TEST KIT AND CONFIRMED BY WESTERN BLOT AT ANY TIME PRIOR TO STUDY ENTRY. HIV-1 CULTURE, HIV-1 ANTIGEN, PLASMA HIV-1 RNA, OR A SECOND ANTIBODY TEST BY A METHOD OTHER THAN ELISA IS ACCEPTABLE AS AN ALTERNATIVE CONFIRMATORY TEST. 2. INITIATED HAART WITHIN ONE YEAR PRIOR TO STUDY ENTRY. HAART IS DEFINED AS A REGIMEN CONSISTING OF THE FOLLOWING DRUG(S) AND/OR DRUG CLASSES: 2 NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs) TOGETHER WITH A) A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI); B) AT LEAST ONE PROTEASE INHIBITOR (PI); C) AT LEAST ONE INTEGRASE OR ENTRY INHIBITOR. A REGIMEN CONTAINING AN NRTI, NNRTI, AND A PI OR AN NRTI, NNRTI AND AT LEAST ONE INTEGRASE OR ENTRY INHIBITOR IS ALSO ACCEPTABLE. 3. MEN AN WOMEN WHO HAVE REACHED THE LEGAL AGE OF MAJORITY IN THE COUNTRY WHERE THEY ARE BEING ENROLLED. 4. ABILITY AND WILLINGNESS OF POTENTIAL PARTICIPANT TO PROVIDE INFORMED CONSENT. 5. WILLINGNESS TO DISCUSS PERSONAL TOPICS DURING AN AUDIO-TAPED GROUP INTERVIEW. 6. WILLINGNESS TO PROTECT THE CONFIDENTIALITY OF OTHER FOCUS GROUP PARTICIPANTS.
Exclusion criteria
Exclusion criteria: 4.2 EXCLUSION CRITERIA - STAGE 1 4.2.1 EXCLUSION CRITERIA FOR HIV-1 INFECTED INDIVIDUALS ON HAART 1. FAILURE TO REMAIN ON HAART FOR AT LEAST THIRTY CONSECUTIVE DAYS. 2. DIMINISHED COGNITIVE CAPACITY THAT, IN THE OPINION OF THE SCREENING CRS CLINICIAN, WOULD INTERFERE WITH STUDY PARTICIPATION. 3. PARTICIPATION IN ANY PRIOR A5250 FOCUS GROUP. 4.2.2 EXCLUSION CRITERIA FOR HEALTCARE PROVIDERS/PROFESSIONALS 1. HEALTCARE PROVIDERS/PROFESSIONALS WHO WILL BE INVOLVED IN ADMINISTERING SOC TREATMENT AND ADHERENCE COUNSELING TO STAGE 2 PARTICIPANTS RANDOMIZED TO THE SOC ARM OR CRS INVESTIGATORS OR HEALTCARE PROVIDERS/PROFESSIONALS DIRECTLY INVOLVED IN MEASURING ADHERENCE OUTCOMES IN STAGE 2. 2. PARTICIPATION IN ANY PRIOR A5250 FOCUS GROUP.
Countries
India, United States
Outcome results
None listed